Nifty
Sensex
:
:
14617.85
48832.03
36.40 (0.25%)
28.35 (0.06%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524689 | NSE: PDPL

Not traded in the last 30 days
  • Open
  • High
  • Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10.38
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 645.85
  • N/A
  • -0.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.28%
  • 2.86%
  • 21.96%
  • FII
  • DII
  • Others
  • 0%
  • 0.01%
  • 1.89%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -23.79
  • -34.30
  • -47.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -16.30
  • 65.59

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -0.43
  • 0.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.53
  • -1.42
  • -0.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.71
  • -38.59
  • -56.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
2.04
7.24
-71.82%
4.64
7.34
-36.78%
2.92
8.72
-66.51%
8.79
3.79
131.93%
Expenses
4.91
10.20
-51.86%
11.11
11.00
1.00%
8.75
12.69
-31.05%
12.67
11.66
8.66%
EBITDA
-2.87
-2.96
-
-6.47
-3.66
-
-5.83
-3.97
-
-3.88
-7.87
-
EBIDTM
-140.94%
-40.94%
-139.37%
-49.71%
-199.59%
-45.58%
-44.16%
-207.55%
Other Income
0.01
0.01
0.00%
0.01
0.01
0.00%
0.01
0.01
0.00%
0.00
0.00
0
Interest
32.09
28.08
14.28%
31.03
27.16
14.25%
29.85
25.99
14.85%
28.72
24.91
15.30%
Depreciation
4.34
4.34
0.00%
4.34
4.34
0.00%
4.34
4.34
0.00%
4.32
55.20
-92.17%
PBT
-39.29
-35.38
-
-41.82
-35.15
-
-40.00
-34.30
-
-36.92
-87.97
-
Tax
-8.31
-9.24
-
-8.15
-6.83
-
-7.78
-6.61
-
-4.98
-16.02
-
PAT
-30.98
-26.14
-
-33.68
-28.31
-
-32.22
-27.69
-
-31.94
-71.96
-
PATM
-1,520.62%
-361.11%
-725.62%
-385.59%
-1,103.70%
-317.65%
-363.43%
-1,898.60%
EPS
-10.39
-8.77
-
-11.29
-9.50
-
-10.81
-9.29
-
-10.71
-24.13
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
18.39
31.87
32.01
223.91
229.75
260.27
262.67
273.70
327.43
332.51
482.22
Net Sales Growth
-32.12%
-0.44%
-85.70%
-2.54%
-11.73%
-0.91%
-4.03%
-16.41%
-1.53%
-31.05%
 
Cost Of Goods Sold
5.24
6.32
6.46
143.98
153.96
183.70
126.44
164.78
194.10
180.76
281.69
Gross Profit
13.15
25.55
25.55
79.93
75.79
76.57
136.23
108.92
133.33
151.75
200.53
GP Margin
71.50%
80.17%
79.82%
35.70%
32.99%
29.42%
51.86%
39.80%
40.72%
45.64%
41.58%
Total Expenditure
37.44
46.56
49.67
225.09
252.13
296.02
248.36
349.63
341.45
318.59
432.45
Power & Fuel Cost
-
9.57
10.87
11.67
12.21
12.48
15.01
14.63
16.72
11.80
14.50
% Of Sales
-
30.03%
33.96%
5.21%
5.31%
4.80%
5.71%
5.35%
5.11%
3.55%
3.01%
Employee Cost
-
19.21
19.94
21.93
20.82
16.87
23.58
24.95
21.28
24.62
25.77
% Of Sales
-
60.28%
62.29%
9.79%
9.06%
6.48%
8.98%
9.12%
6.50%
7.40%
5.34%
Manufacturing Exp.
-
6.80
7.09
10.98
11.57
21.74
21.85
32.00
35.70
19.46
20.25
% Of Sales
-
21.34%
22.15%
4.90%
5.04%
8.35%
8.32%
11.69%
10.90%
5.85%
4.20%
General & Admin Exp.
-
4.09
5.22
14.11
25.58
27.17
25.60
29.16
29.02
37.28
47.07
% Of Sales
-
12.83%
16.31%
6.30%
11.13%
10.44%
9.75%
10.65%
8.86%
11.21%
9.76%
Selling & Distn. Exp.
-
0.14
0.24
19.08
7.14
9.79
35.80
37.64
44.41
44.15
43.17
% Of Sales
-
0.44%
0.75%
8.52%
3.11%
3.76%
13.63%
13.75%
13.56%
13.28%
8.95%
Miscellaneous Exp.
-
0.44
-0.15
3.33
20.86
24.27
0.07
46.47
0.20
0.52
43.17
% Of Sales
-
1.38%
-0.47%
1.49%
9.08%
9.32%
0.03%
16.98%
0.06%
0.16%
0%
EBITDA
-19.05
-14.69
-17.66
-1.18
-22.38
-35.75
14.31
-75.93
-14.02
13.92
49.77
EBITDA Margin
-103.59%
-46.09%
-55.17%
-0.53%
-9.74%
-13.74%
5.45%
-27.74%
-4.28%
4.19%
10.32%
Other Income
0.03
0.25
1.44
1.59
5.75
2.05
0.96
60.77
0.25
0.44
0.60
Interest
121.69
109.96
96.05
97.54
85.77
69.88
70.25
60.21
55.85
48.41
28.55
Depreciation
17.34
17.35
69.12
24.24
24.89
22.79
30.98
18.62
23.00
14.47
12.57
PBT
-158.03
-141.74
-181.40
-121.37
-127.29
-126.36
-85.95
-94.00
-92.62
-48.52
9.25
Tax
-29.22
-27.66
-33.49
-9.56
-9.56
-10.36
-18.70
-1.39
15.22
4.84
4.24
Tax Rate
18.49%
19.51%
18.46%
7.88%
7.50%
8.16%
21.65%
2.99%
-16.43%
-9.98%
45.84%
PAT
-128.82
-114.07
-147.91
-111.81
-117.83
-116.55
-67.66
-45.17
-107.84
-53.38
4.42
PAT before Minority Interest
-128.82
-114.07
-147.91
-111.81
-117.83
-116.55
-67.66
-45.17
-107.84
-53.36
5.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.02
-0.59
PAT Margin
-700.49%
-357.92%
-462.07%
-49.94%
-51.29%
-44.78%
-25.76%
-16.50%
-32.94%
-16.05%
0.92%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-43.23
-38.28
-49.63
-37.52
-39.54
-39.11
-22.70
-15.16
-36.19
-17.91
1.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
-561.31
-446.92
-136.44
-17.44
325.38
127.10
202.33
246.22
349.06
332.44
Share Capital
29.82
29.82
29.82
29.82
47.70
45.20
45.20
43.24
37.83
32.33
Total Reserves
-591.12
-476.74
-166.25
-47.26
277.68
81.90
157.13
191.98
272.00
275.89
Non-Current Liabilities
-25.79
4.47
370.10
461.57
440.18
427.02
455.62
426.79
245.56
178.44
Secured Loans
0.00
0.00
252.72
323.96
379.40
328.32
359.71
358.89
201.43
121.11
Unsecured Loans
107.20
109.67
181.12
179.21
56.40
83.96
62.44
30.36
21.59
39.37
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
1,005.70
877.55
592.56
427.55
299.78
229.77
165.98
161.66
254.23
243.73
Trade Payables
7.93
11.87
51.20
42.58
38.91
61.24
44.73
59.72
77.98
60.69
Other Current Liabilities
988.31
857.30
379.59
223.61
100.28
58.31
36.78
12.99
11.59
11.03
Short Term Borrowings
0.00
0.00
153.36
153.12
152.21
101.54
73.98
83.64
159.91
165.02
Short Term Provisions
9.46
8.38
8.41
8.25
8.37
8.68
10.49
5.31
4.75
6.99
Total Liabilities
418.72
435.22
826.50
871.96
1,065.99
784.54
824.58
835.32
849.50
755.25
Net Block
339.14
356.49
715.80
738.66
891.82
542.42
570.97
609.95
499.97
405.57
Gross Block
786.36
786.36
915.41
914.02
1,042.30
670.10
668.42
696.00
563.12
454.75
Accumulated Depreciation
447.22
429.88
199.60
175.36
150.47
127.68
97.45
86.04
63.15
49.18
Non Current Assets
351.26
367.91
727.46
750.26
901.99
548.82
619.14
628.93
629.90
524.18
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.87
4.23
116.27
78.99
Non Current Investment
2.40
2.40
0.00
0.52
0.02
0.01
0.03
0.03
0.03
0.03
Long Term Loans & Adv.
7.21
6.54
8.09
6.79
10.15
6.39
47.28
14.72
13.62
25.80
Other Non Current Assets
2.51
2.49
3.56
4.29
0.00
0.00
0.00
0.00
0.00
13.78
Current Assets
67.47
67.31
99.05
121.70
163.15
234.86
199.96
192.10
201.45
231.07
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.00
Inventories
1.26
3.97
27.01
45.05
56.27
80.27
57.69
64.26
73.91
90.88
Sundry Debtors
0.00
0.00
3.66
62.33
92.42
139.37
120.49
78.95
91.90
107.51
Cash & Bank
0.11
0.45
3.55
3.23
4.57
3.08
8.24
10.50
13.33
8.18
Other Current Assets
66.10
56.70
56.70
0.00
9.89
12.14
13.54
38.38
22.31
20.50
Short Term Loans & Adv.
9.40
6.19
8.12
11.09
9.54
11.69
13.29
38.16
21.81
20.18
Net Current Assets
-938.24
-810.24
-493.52
-305.85
-136.63
5.09
33.99
30.44
-52.78
-12.66
Total Assets
418.73
435.22
826.51
871.96
1,065.99
784.55
824.57
835.33
849.50
755.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
112.36
477.03
166.95
134.40
57.97
1.65
-60.20
-167.50
19.63
77.72
PBT
-141.74
-181.40
-141.25
-127.39
-126.36
-85.95
-94.00
-92.62
-48.52
9.25
Adjustment
127.88
164.70
121.82
109.51
92.67
101.23
78.83
79.34
63.37
41.62
Changes in Working Capital
126.22
472.76
186.38
152.20
139.44
64.63
-38.37
-98.16
53.45
58.92
Cash after chg. in Working capital
112.36
456.06
166.95
134.32
105.75
79.90
-53.54
-111.44
68.30
109.79
Interest Paid
0.00
0.00
0.00
0.00
-69.88
-70.25
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
-0.02
0.00
-0.03
-2.69
-0.22
-0.26
-3.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
20.98
0.00
0.10
22.10
-7.97
0.00
0.00
0.00
0.00
Cash From Investing Activity
0.08
96.58
-0.62
-0.54
-110.00
3.05
32.56
-17.59
-147.02
-113.43
Net Fixed Assets
0.00
0.01
-1.35
-0.01
-371.70
-2.05
-9.68
-7.47
-35.25
-100.85
Net Investments
0.00
0.00
0.47
135.64
0.54
0.41
0.00
0.00
0.00
-0.11
Others
0.08
96.57
0.26
-136.17
261.16
4.69
42.24
-10.12
-111.77
-12.47
Cash from Financing Activity
-112.43
-573.59
-166.62
-134.35
53.51
-9.86
25.39
182.26
132.54
31.07
Net Cash Inflow / Outflow
0.01
0.02
-0.28
-0.48
1.49
-5.16
-2.26
-2.83
5.15
-4.64
Opening Cash & Equivalents
0.10
0.08
0.36
0.84
3.08
8.24
10.50
13.33
8.18
12.82
Closing Cash & Equivalent
0.11
0.10
0.08
0.36
4.57
3.08
8.24
10.50
13.33
8.18

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
-212.42
-174.06
-134.09
-94.18
14.51
36.78
60.46
78.23
107.67
116.19
ROA
-26.72%
-23.45%
-13.17%
-12.16%
-12.60%
-8.41%
-5.44%
-12.80%
-6.65%
0.71%
ROE
0.00%
0.00%
0.00%
0.00%
-152.43%
-46.67%
-23.61%
-44.85%
-18.43%
1.63%
ROCE
-52.31%
-35.07%
-5.55%
-6.91%
-8.13%
-2.29%
1.90%
-5.15%
-0.02%
6.11%
Fixed Asset Turnover
0.04
0.04
0.25
0.24
0.32
0.41
0.42
0.54
0.67
1.14
Receivable days
0.00
0.00
53.24
118.09
154.45
171.12
128.21
91.76
106.99
86.73
Inventory Days
29.92
176.56
58.14
77.32
90.99
90.86
78.40
74.21
88.41
66.36
Payable days
62.05
100.11
80.00
64.37
74.10
69.65
65.04
76.76
88.78
47.13
Cash Conversion Cycle
-32.13
76.45
31.38
131.05
171.33
192.33
141.57
89.20
106.62
105.95
Total Debt/Equity
-1.00
-1.23
-1.92
-2.75
10.66
4.52
2.68
2.20
1.32
1.06
Interest Cover
-0.29
-0.89
-0.24
-0.49
-0.82
-0.23
0.23
-0.66
0.00
1.32

Top Investors:

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.